Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples